A Phase 2 Study to Compare the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 2 Dose Regimens of IW-1973 in Patients With Stable Type 2 Diabetes and Hypertension
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs IW 1973 (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Ironwood Pharmaceuticals
- 11 Oct 2017 Status changed from recruiting to completed.
- 08 May 2017 Data from this trial are expected in the second half of 2017, according to an Ironwood Pharmaceuticals media release.
- 30 Mar 2017 New trial record